| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | DE202004013521U1 Composition containing beta-glucan and nucleotide, useful, particularly in animals, for stimulation of the immune system, e.g. during convalescence |
| 01/05/2006 | DE102004029784A1 Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel New 2-Benzylaminodihydropteridinone, process for their preparation and their use as medicaments |
| 01/05/2006 | DE102004028973A1 Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydro-2H-isoquinolin-1-one derivatives, to processes for their preparation and their use as a medicament |
| 01/05/2006 | DE102004028899A1 Mittel zur Steigerung der Aktivität der sekretorischen Phospholipase A2-IIA Means for enhancing the activity of the secretory phospholipase A2-IIA |
| 01/05/2006 | DE102004028751A1 New 4-heterocyclyl-1-acyl-piperidine derivatives, useful e.g. for treating headache, diabetes and cardiovascular disease, are antagonists of calcitonin-gene related peptide |
| 01/05/2006 | DE102004028284A1 Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin Controlled matrix transdermal therapeutic system based on a hot melt adhesive for use of norelgestromin |
| 01/05/2006 | DE102004028241A1 Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New fluoroglycoside derivatives of pyrazoles, pharmaceutical compositions containing them and their use |
| 01/05/2006 | DE102004028156A1 Combination of radio waves and one or more of monoclonal antibodies, tyrosine-kinase inhibitors, angiogenesisi inhibitors, farnesyl transferase inhibitors, topoisomerase - I or II inhibitors, cytokine and antisense oligonucleotides |
| 01/05/2006 | DE102004027821A1 Benzimidazole, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel Benzimidazoles, process for their preparation and their use as medicaments |
| 01/05/2006 | DE102004026532A1 Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung Substituted oxazole Benzoisothiazoldioxidderivate, processes for their preparation and their use |
| 01/05/2006 | DE102004025881A1 Oligoribonukleotide zur Beeinflussung des Haarwachstums Oligoribonucleotides for influencing of hair growth |
| 01/05/2006 | DE102004024453A1 Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen New long-acting bronchodilators for the treatment of respiratory disorders |
| 01/05/2006 | DE102004004965B4 Verfahren zur Herstellung eines 2-(Ethoxymethyl)-tropanderivates A process for preparing a 2- (ethoxymethyl) -tropanderivates |
| 01/05/2006 | DE102004004901B4 Verfahren zur Herstellung von Sorbicillacton A A process for the preparation of sorbicillacton |
| 01/05/2006 | CA2810655A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2612006A1 Phospholipid compositions and methods for their preparation and use |
| 01/05/2006 | CA2589565A1 Amido compounds and their use as pharmaceuticals |
| 01/05/2006 | CA2588571A1 Insulin secretagogue drugs |
| 01/05/2006 | CA2584502A1 2-methylpropanamides and their use as pharmaceuticals |
| 01/05/2006 | CA2584493A1 Kinase inhibitors for treating cancers |
| 01/05/2006 | CA2579716A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists |
| 01/05/2006 | CA2578595A1 Tobacco alkaloid releasing chewing gum |
| 01/05/2006 | CA2574206A1 Phenothiazine derivatives and their method of use |
| 01/05/2006 | CA2572328A1 2-aminoarylcarboxamides useful as cancer chemotherapeutic agents |
| 01/05/2006 | CA2572259A1 Sanitizing composition |
| 01/05/2006 | CA2572193A1 Treatment of conditions involving oligodendrocytes with sp35 based agents |
| 01/05/2006 | CA2572141A1 3'-alkoxy spirocyclic tetramic and tetronic acids |
| 01/05/2006 | CA2572136A1 Novel imidazoles and triazoles, the production thereof, and the use of the same as medicaments |
| 01/05/2006 | CA2572135A1 Sulfonamide compound |
| 01/05/2006 | CA2571990A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides |
| 01/05/2006 | CA2571949A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2571852A1 Inhibition of infiltration, and cell killing agent |
| 01/05/2006 | CA2571718A1 Compounds for the treatment of an acute injury to the central nervous system |
| 01/05/2006 | CA2571717A1 Compounds for the treatment of inflammation of the central nervous system |
| 01/05/2006 | CA2571712A1 Novel indazole carboxamides and their use |
| 01/05/2006 | CA2571675A1 5-aza-7-deazapurine derivatives for treating infections with flaviviridae |
| 01/05/2006 | CA2571584A1 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 01/05/2006 | CA2571569A1 Use of targeted oxidative therapeutic formulation in endodontic treatment |
| 01/05/2006 | CA2571558A1 Novel uses of porphyrin compounds |
| 01/05/2006 | CA2571555A1 Diazabicyclic histamine-3 receptor antagonists |
| 01/05/2006 | CA2571529A1 Substituted diketopiperazines as oxytocin antagonists |
| 01/05/2006 | CA2571527A1 Piperazinediones as oxytocin receptor antagonists |
| 01/05/2006 | CA2571505A1 New mao-b inhibitors |
| 01/05/2006 | CA2571449A1 Compositions comprising strontium and vitamin d and uses thereof |
| 01/05/2006 | CA2571447A1 Composition and method for treatment and prevention of atherosclerosis |
| 01/05/2006 | CA2571444A1 Compositions for topical treatment |
| 01/05/2006 | CA2571443A1 Pyridyl piperazines for the treatment of cns disorders |
| 01/05/2006 | CA2571433A1 Solid and crystalline ibandronic acid |
| 01/05/2006 | CA2571431A1 Arrays with cleavable linkers |
| 01/05/2006 | CA2571421A1 Compounds for immunopotentiation |
| 01/05/2006 | CA2571356A1 Novel hexafluoroisopropanol derivatives |
| 01/05/2006 | CA2571316A1 Vaccination of skunks and/or mongooses against rabies |
| 01/05/2006 | CA2571309A1 Chemical compounds |
| 01/05/2006 | CA2571258A1 Amido compounds and their use as pharmaceuticals |
| 01/05/2006 | CA2571183A1 Composition comprising lactic acid and lactoferrin |
| 01/05/2006 | CA2571087A1 Novel piperidine derivates as modulators of chemokine receptor ccr5 |
| 01/05/2006 | CA2571058A1 Cannabinoid receptor ligands |
| 01/05/2006 | CA2571049A1 Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| 01/05/2006 | CA2571012A1 Tricyclic compounds and their use as mglur1 antagonists |
| 01/05/2006 | CA2571002A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 01/05/2006 | CA2570976A1 Methods of treatment of endobronchial infections |
| 01/05/2006 | CA2570961A1 Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities |
| 01/05/2006 | CA2570893A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
| 01/05/2006 | CA2570884A1 Carbazole formulations for the treatment of psoriasis and angiogenesis |
| 01/05/2006 | CA2570873A1 Pyrimidine urea derivatives as kinase inhibitors |
| 01/05/2006 | CA2570820A1 Basic salts and monohydrates of certain alpha, beta-proprionic acid derivative |
| 01/05/2006 | CA2570818A1 Indolylalkylamine metabolites as 5-hydroxytrytamine-6 ligands |
| 01/05/2006 | CA2570813A1 Lactam tachykinin receptor antagonists |
| 01/05/2006 | CA2570796A1 Stable pharmaceutical formulations of benzimidazole compounds |
| 01/05/2006 | CA2570754A1 Use of targeted oxidative therapeutic formulation in treatment of burns |
| 01/05/2006 | CA2570673A1 Compounds and methods for treating dyslipidemia |
| 01/05/2006 | CA2570665A1 Poly-gamma-glutamic acid-vitamin complex and use thereof |
| 01/05/2006 | CA2570619A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 01/05/2006 | CA2570615A1 Drugs for treating duplication of hypertension with hyperuricemia and /or hypercholesterolemia |
| 01/05/2006 | CA2570596A1 Use of meloxicam in veterinary medicine for the treatment of inflammatory painful diseases |
| 01/05/2006 | CA2570570A1 Compositions and methods for the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide |
| 01/05/2006 | CA2570552A1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 01/05/2006 | CA2570499A1 Method for producing 4-(benzimidazolylmethylamino)-benzamidines |
| 01/05/2006 | CA2568857A1 Lxr agonists to promote bone homeostasis |
| 01/05/2006 | CA2568804A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 01/05/2006 | CA2568802A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists |
| 01/05/2006 | CA2568752A1 Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 01/05/2006 | CA2567977A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/05/2006 | CA2567851A1 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 01/05/2006 | CA2567848A1 Methods and compositions for treating neuropathies |
| 01/05/2006 | CA2567602A1 Compositions and methods relating to pyrimidine synthesis inhibitors |
| 01/05/2006 | CA2567365A1 Use of reboxetine for the treatment of pain |
| 01/05/2006 | CA2565437A1 Factor xa inhibitors |
| 01/05/2006 | CA2560671A1 Crystalline forms of n-desmethylclozapine |
| 01/05/2006 | CA2559824A1 Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril |
| 01/05/2006 | CA2547979A1 Process for the preparation of anastrozole |
| 01/04/2006 | EP1612555A1 Cryptic peptides for use in inducing immunologic tolerance |
| 01/04/2006 | EP1612280A2 Diagnosis and treatment of Williams syndrome |
| 01/04/2006 | EP1612270A2 Rétroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612225A1 Modified acacia and use thereof |
| 01/04/2006 | EP1612212A1 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
| 01/04/2006 | EP1612211A1 Novel carbapenem compounds |